📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. (2020)

First Author: Mackenzie JS
Attributed to:  Defining the metabolic phenotype of intracellular Mycobacterium tuberculosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-19959-4

PubMed Identifier: 33257709

Publication URI: http://europepmc.org/abstract/MED/33257709

Type: Journal Article/Review

Volume: 11

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723